COVID-19 Delta Variant Can Evade Immune Responses Easily; Fully Resistant to Key Antibody Used for Treatment [Study]

COVID-19 Delta Variant Can Evade Immune Responses Easily; Fully Resistant to Key Antibody Used for Treatment [Study]

While our drastically altered lives due to the COVID-19 pandemic appear to remain unchanged for the foreseeable future, the SARS-CoV-2 virus is evolving at an unprecedented rate. One such VOC is the Delta variant (B.1.617.2). According to the multi-institutional study, the Delta variant, which was previously known as the Indian variant, is fully resistant to the therapeutic antibody bamlanivimab.

Read more at 
IBTimes India

Timeline

.......... .......... .......... .......... ..........
  • .......... .......... .......... .......... .......... .......... .......... .......... .......... .......... .......... ..........
.......... .......... .......... .......... ..........
  • .......... .......... .......... .......... .......... .......... .......... .......... .......... .......... .......... ..........
  • .......... .......... .......... .......... .......... .......... .......... .......... .......... .......... .......... ..........
.......... .......... .......... .......... ..........
  • .......... .......... .......... .......... .......... .......... .......... .......... .......... .......... .......... ..........

In-depth coverage

Read more top Science stories on Crisp